Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06363305 · ClinicalTrials.gov registry record · NA

Impact of Sex in the Effect of Dietary Capsaicin on Cardiovascular Health

A NA study of Hypertension and Prehypertension, sponsored by Skidmore College.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT06363305: Recruiting NA study of Hypertension and Prehypertension, sponsored by Skidmore College.

NCT06363305 is a NA study of Hypertension and Prehypertension that is actively recruiting participants, run by Skidmore College. The registered enrollment target is 80 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06363305, a NA study of Hypertension and Prehypertension, is actively recruiting participants, sponsored by Skidmore College.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The investigators long-term goal is to better understand novel interventions to promote cardiovascular health in humans. The goal of the proposed research is to investigate whether there is sex-specificity in the effects of dietary capsaicin on mechanisms regulating nitric oxide (NO) bioavailability, its effect on key markers of cardiovascular (CV) health, including BP, macro- and microvascular function, and arterial stiffness. This knowledge will provide critical insight into the effects of dietary capsaicin on CV health and will guide future trials.

Interventions

  • DIETARY_SUPPLEMENT Dietary capsules

Study Locations (1)

New York

  • Skidmore College - Saratoga Springs

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-07-08
Est. Completion 2025-12-31
Phase NA
Skidmore College

13 total trials

What NCT06363305 shows while recruiting

NCT06363305 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Dietary capsules is the first listed.

NCT06363305 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06363305 about?

NCT06363305 is a clinical study titled "Impact of Sex in the Effect of Dietary Capsaicin on Cardiovascular Health". The investigators long-term goal is to better understand novel interventions to promote cardiovascular health in humans. The goal of the proposed research is to investigate whether there is sex-specificity in the effects of dietary capsaicin on mechanisms regulating nitric oxide (NO) bioavailability...

What is the current status of trial NCT06363305?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-07-08. Estimated completion is 2025-12-31.

What conditions does trial NCT06363305 study?

This clinical trial studies the following conditions: Hypertension, Prehypertension.

What interventions are being tested in trial NCT06363305?

The interventions under investigation include: Dietary capsules (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06363305?

This trial is sponsored by Skidmore College, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06363305 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06363305's enrollment target sits among peer trials

80 316th of 470 higher than 150 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06363305, the US trial registry maintained by the National Library of Medicine. NCT06363305 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.